Kolexia
Mesgouez-Nebout Nathalie Oncologie radiothérapie
Mesgouez-Nebout Nathalie
Oncologie radiothérapie
Ico - Site Paul Papin
Angers, France
48 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Carcinomes Tumeurs du rectum Tumeurs de la prostate Tumeurs du sein Métastase tumorale Ostéoporose Tumeurs du col de l'utérus Chéloïde Cicatrice

Collaborateurs

Voir plus
Abadie-Lacourtoisie Sophie
Abadie-Lacourtoisie Sophie
Ico - Site Paul Papin, Angers, France
Colliaux Jeremy
Colliaux Jeremy
Ico - Site Paul Papin, Angers, France
Cellier Patrice
Cellier Patrice
Institut de cancérologie de l'Ouest, Saint-Herblain, France
Hamidou Hadji
Hamidou Hadji
Ico - Site Paul Papin, Angers, France

Industries

Voir plus
Ipsen
6 collaboration(s)
Dernière en 2023
Astellas
4 collaboration(s)
Dernière en 2023
Bouchara-Recordati
2 collaboration(s)
Dernière en 2022
AstraZeneca
2 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
REPAIR: Relapse in Previously Irradiated Prostate Bed : a Phase I/II Study of Stereotactic Ablative Reirradiation Potentiated by Metformin
Essai Clinique (Institut Cancerologie de l'Ouest)   11 mars 2024
BLAD-RAD01: Consolidative Radiotherapy for Metastatic Urothelial Bladder Cancer Patients Without Progression and With no More Than Three Residual Metastatic Lesions Following First Line Systemic Therapy: a Prospective Randomized Comparative Phase II Trial
Essai Clinique (Institut Universitaire du Cancer Toulouse Oncopole)   01 février 2024
Prospective results for 5-year survival and toxicity of moderately hypofractionated radiotherapy with simultaneous integrated boost (SIB) in (very) high-risk prostate cancer.
Clinical and translational radiation oncology   17 novembre 2023
Néofirinox: Randomized Phase III Study Comparing Preoperative Chemoradiotherapy Alone Versus Neoadjuvant Chemotherapy With Folfirinox Regimen Followed by Preoperative Chemoradiotherapy for Patients With Resectable Locally Advanced Rectal Cancer
Essai Clinique (Unicancer)   30 août 2023
GETUG-StORM-01: A Randomized Phase II Study Assessing Stereotactic Radiotherapy in Therapeutic Strategy of Oligoprogressive Renal Cell Carcinoma Metastases
Essai Clinique (Centre François-Baclesse)   31 juillet 2023
Cost and Toxicity Comparisons of Two IMRT Techniques for Prostate Cancer: A Micro-Costing Study and Weighted Propensity Score Analysis Based on a Prospective Study.
Frontiers in oncology   11 janvier 2022
Consolidative radiotherapy for metastatic urothelial bladder cancer patients without progression and with no more than three residual metastatic lesions following first line systemic therapy: A prospective randomized comparative phase II trial (BLAD RAD01/GETUG-AFU V07).
2021 ASCO Annual Meeting I   28 mai 2021
Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial.
The Lancet. Oncology   13 avril 2021
LBA21 Neoadjuvant mFOLFIRINOX and preoperative chemoradiation (CRT) versus preoperative CRT in patients with T3-4 rectal cancer: Surgical and quality of life results of PRODIGE 23 phase III trial
Abstract Book of the ESMO Virtual Congress2020 19 – 21 September / 16 – 18 October 2020   01 septembre 2020
Corrigendum to 'clinical and genetic landscape of treatment naive cervical cancer: Alterations in PIK3CA and in epigenetic modulators associated with sub-optimal outcome'.
EBioMedicine   07 juillet 2020